Copay help by condition · Cancer and blood cancer · read 2026-11-08
Ovarian Cancer: which charitable copay funds are open
4 funds for Ovarian Cancer say it is open right now, of the 5 we hold (read 2026-11-08).
Open: Ovarian Cancer from CancerCare, Ovarian Cancer - Medicare Access from HealthWell Foundation, Ovarian cancer from TotalAssist (Patient Advocate Foundation copay funds) and Ovarian cancer health equity from TotalAssist (Patient Advocate Foundation copay funds). Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Ovarian Cancer
- OpenOvarian Cancer
CancerCare ·
Award level: not statedInsurance supported: not stated
The page marks the fund as open for new enrollments (the fund row's own data-statuses attribute reads open). Source page
- OpenOvarian Cancer - Medicare Access
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Open. Source page
- OpenOvarian cancer
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $4,000Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Open. Source page
- OpenOvarian cancer health equity
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $4,000Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Open. Source page
- Closed or at capacityOvarian Cancer
Good Days ·
Award level: not statedInsurance supported: not stated
The page marks the fund as seeking funds for new enrollments (the fund's list item on the page carries the class seeking), so it is not open to applications. Source page
Drugs whose FDA label names Ovarian Cancer
2 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 2 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Zejula Niraparib Tosylate Every route for this drug | Maintenance Treatment of Recurrent Ovarian Cancer ZEJULA ® is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial ... Label on openFDA, read 2026-11-10 | GSK Patient Assistance Program (GSK ViiV Healthcare Patient Access Programs Foundation) (program page) | not in the CMS negotiated-price file |
| Lynparza Olaparib Every route for this drug | Ovarian cancer • for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA -mutated advanced epithelial ovarian, fallopian tube or primary ... Label on openFDA, read 2026-11-10 | Cancer Drug Assistance (Multiple Programs) AZ&Me Prescription Savings Program Limited | not in the CMS negotiated-price file |
Funds for costs around Ovarian Cancer
These pay for a kind of cost, not a diagnosis. Each is shown with its own status.
Funds for costs around cancer and blood cancer in general: behavioral health (1 open of 2), caregiver support (0 open of 2), clinical trial costs (0 open of 1), home care (1 open of 1), named fund (0 open of 1), pain management (0 open of 1), testing (1 open of 1) and transportation (0 open of 1). Every one is listed, with its source, on the Cancer and blood cancer page.
Related conditions
No broader or more specific condition page for this one.
Group: Cancer and blood cancer. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: ovarian-cancer.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Ovarian Cancer?
As read on 2026-11-08, 4 of the 5 funds we hold for Ovarian Cancer say they are open: Ovarian Cancer from CancerCare, Ovarian Cancer - Medicare Access from HealthWell Foundation, Ovarian cancer from TotalAssist (Patient Advocate Foundation copay funds) and Ovarian cancer health equity from TotalAssist (Patient Advocate Foundation copay funds). Funds open and close, so check the source page before you apply.
Which organizations run funds for Ovarian Cancer?
CancerCare, HealthWell Foundation, TotalAssist (Patient Advocate Foundation copay funds) and Good Days. Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.